Financials Kewaunee Scientific Corporation

Equities

KEQU

US4928541048

Business Support Supplies

Market Closed - Nasdaq 04:30:01 2024-04-26 pm EDT 5-day change 1st Jan Change
34.9 USD -2.92% Intraday chart for Kewaunee Scientific Corporation -1.30% +20.06%

Valuation

Fiscal Period: Abril 2018 2019 2020 2021 2022 2023
Capitalization 1 95.24 62.16 28.14 33.15 39.78 45.99
Enterprise Value (EV) 1 91.84 62.43 37.69 44.1 74.14 79.61
P/E ratio 18.7 x 41.1 x -6 x -9.02 x -6.48 x 65 x
Yield 1.89% 3.27% 3.71% - - -
Capitalization / Revenue 0.6 x 0.42 x 0.19 x 0.22 x 0.24 x 0.21 x
EV / Revenue 0.58 x 0.43 x 0.26 x 0.3 x 0.44 x 0.36 x
EV / EBITDA 7.75 x 12.8 x 72.1 x 181 x 85.3 x 9.75 x
EV / FCF -78 x -79.2 x 14.2 x -34.2 x -3.87 x 18.9 x
FCF Yield -1.28% -1.26% 7.03% -2.92% -25.9% 5.29%
Price to Book 2.03 x 1.32 x 0.73 x 0.8 x 1.11 x 1.23 x
Nbr of stocks (in thousands) 2,725 2,747 2,751 2,763 2,790 2,830
Reference price 2 34.95 22.63 10.23 12.00 14.26 16.25
Announcement Date 7/20/18 7/11/19 7/27/20 7/15/21 7/1/22 6/30/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Abril 2018 2019 2020 2021 2022 2023
Net sales 1 158 146.6 147.5 147.5 168.9 219.5
EBITDA 1 11.85 4.89 0.523 0.243 0.869 8.167
EBIT 1 9.086 2.319 -2.131 -2.444 -1.9 5.3
Operating Margin 5.75% 1.58% -1.44% -1.66% -1.13% 2.41%
Earnings before Tax (EBT) 1 9.48 2.134 -2.866 -2.617 -2.485 4.498
Net income 1 5.188 1.529 -4.687 -3.672 -6.126 0.738
Net margin 3.28% 1.04% -3.18% -2.49% -3.63% 0.34%
EPS 2 1.870 0.5500 -1.704 -1.330 -2.200 0.2500
Free Cash Flow 1 -1.177 -0.788 2.648 -1.288 -19.17 4.211
FCF margin -0.74% -0.54% 1.79% -0.87% -11.35% 1.92%
FCF Conversion (EBITDA) - - 506.31% - - 51.56%
FCF Conversion (Net income) - - - - - 570.56%
Dividend per Share 2 0.6600 0.7400 0.3800 - - -
Announcement Date 7/20/18 7/11/19 7/27/20 7/15/21 7/1/22 6/30/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: April 2018 2019 2020 2021 2022 2023
Net Debt 1 - 0.28 9.55 10.9 34.4 33.6
Net Cash position 1 3.4 - - - - -
Leverage (Debt/EBITDA) - 0.0571 x 18.26 x 45.03 x 39.54 x 4.116 x
Free Cash Flow 1 -1.18 -0.79 2.65 -1.29 -19.2 4.21
ROE (net income / shareholders' equity) 11.8% 3.52% -10.7% -9% -15.5% 3.64%
ROA (Net income/ Total Assets) 6.87% 1.68% -1.56% -1.76% -1.14% 2.79%
Assets 1 75.5 90.89 301.2 208.3 536.9 26.48
Book Value Per Share 2 17.20 17.10 14.00 14.90 12.80 13.20
Cash Flow per Share 2 3.560 3.880 1.590 1.880 1.590 2.850
Capex 1 3.4 4.21 2.47 2.4 1.91 4.15
Capex / Sales 2.15% 2.87% 1.67% 1.63% 1.13% 1.89%
Announcement Date 7/20/18 7/11/19 7/27/20 7/15/21 7/1/22 6/30/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. KEQU Stock
  4. Financials Kewaunee Scientific Corporation